Explore more publications!
The Middle East Health Journal
Got News to Share?

The Middle East Health Journal: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The Middle East Health Journal.

November 2025

Mo Tu We Th Fr Sa Su
1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30

December 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30 31

January 2026

Mo Tu We Th Fr Sa Su
1 2 3 4
5 6 7 8 9 10 11
12 13 14 15 16 17 18
19 20 21 22 23 24 25
26 27 28 29 30 31

Press releases published on January 15, 2026

Dubai Duty Free Achieves Certified Autism Center™ Designation
January 15, 2026

Dubai Duty Free Achieves Certified Autism Center™ Designation

Indeterminate EIN Presswire
Strongest Phentermine Alternatives 2026: What OTC Options Actually Exist? Phen24 Consumer Search Analysis and 7-Point Verification Framework
January 15, 2026

Strongest Phentermine Alternatives 2026: What OTC Options Actually Exist? Phen24 Consumer Search Analysis and 7-Point Verification Framework

Indeterminate GlobeNewswire
Serina Therapeutics Receives NYSE Deficiency Notification Regarding Shareholders' Equity
January 15, 2026

Serina Therapeutics Receives NYSE Deficiency Notification Regarding Shareholders' Equity

Indeterminate GlobeNewswire
BriaCell Therapeutics Announces Closing of US$30 million Public Offering
January 15, 2026

BriaCell Therapeutics Announces Closing of US$30 million Public Offering

Indeterminate GlobeNewswire
PainReform Ltd. Changes Name to PRF Technologies Ltd. Reflecting Expansion into Diversified Healthcare and AI-Driven Energy Platforms
January 15, 2026

PainReform Ltd. Changes Name to PRF Technologies Ltd. Reflecting Expansion into Diversified Healthcare and AI-Driven Energy Platforms

Indeterminate GlobeNewswire
Oncolytics Biotech® Announces Results of Special Meeting of Shareholders
January 15, 2026

Oncolytics Biotech® Announces Results of Special Meeting of Shareholders

Indeterminate GlobeNewswire
Bell Integration Enhances AI Training Portfolio in the U.A.E. with Custom Agentic AI Programmes
January 15, 2026

Bell Integration Enhances AI Training Portfolio in the U.A.E. with Custom Agentic AI Programmes

Indeterminate EIN Presswire
Greenhouse Treatment Center Welcomes New Harvard-Trained Addiction Treatment Expert
January 15, 2026

Greenhouse Treatment Center Welcomes New Harvard-Trained Addiction Treatment Expert

Indeterminate GlobeNewswire
Global Immunotherapy Drug Market Projected to Reach $467.4 Billion by 2030
January 15, 2026

Global Immunotherapy Drug Market Projected to Reach $467.4 Billion by 2030

Indeterminate GlobeNewswire
Prestige Senior Living Celebrates 40-Year Legacy, Expands Portfolio, and Launches Proprietary Decision Intelligence Tools
January 15, 2026

Prestige Senior Living Celebrates 40-Year Legacy, Expands Portfolio, and Launches Proprietary Decision Intelligence Tools

Indeterminate GlobeNewswire
Is that assistance dog “real” and properly qualified? Assistance Dog Foundation Launches Independent ISO-Aligned Certification and Global Register for Assistance Dog Teams
January 15, 2026

Is that assistance dog “real” and properly qualified? Assistance Dog Foundation Launches Independent ISO-Aligned Certification and Global Register for Assistance Dog Teams

Indeterminate GlobeNewswire
Foundation for Sarcoidosis Research Announces New Members to the Expanding FSR Global Sarcoidosis Clinic Alliance, Including Its First International Member
January 15, 2026

Foundation for Sarcoidosis Research Announces New Members to the Expanding FSR Global Sarcoidosis Clinic Alliance, Including Its First International Member

Indeterminate GlobeNewswire
At Pharmapack, TekniPlex Healthcare to Unveil Expanded Multidose Packaging Capabilities and Advanced Barrier Materials for Pharmaceutical Applications.
January 15, 2026

At Pharmapack, TekniPlex Healthcare to Unveil Expanded Multidose Packaging Capabilities and Advanced Barrier Materials for Pharmaceutical Applications.

Indeterminate GlobeNewswire
14th Annual State of the Cure for T1D Shows Major Development in Cure Research
January 15, 2026

14th Annual State of the Cure for T1D Shows Major Development in Cure Research

Indeterminate GlobeNewswire
Precipio Takes Major Steps Toward a Clean Balance Sheet
January 15, 2026

Precipio Takes Major Steps Toward a Clean Balance Sheet

Indeterminate GlobeNewswire
CHINA SXT PHARMACEUTICALS, INC. ANNOUNCES STRATEGIC INITIATIVE TO APPLY AI TECHNOLOGY ACROSS THE TCM SUPPLY CHAIN
January 15, 2026

CHINA SXT PHARMACEUTICALS, INC. ANNOUNCES STRATEGIC INITIATIVE TO APPLY AI TECHNOLOGY ACROSS THE TCM SUPPLY CHAIN

Indeterminate GlobeNewswire
GT Biopharma Announces IND Submission for GTB-5550 TriKE®, a B7-H3-targeted natural killer (NK) cell engager for B7-H3 expressing solid tumor cancers
January 15, 2026

GT Biopharma Announces IND Submission for GTB-5550 TriKE®, a B7-H3-targeted natural killer (NK) cell engager for B7-H3 expressing solid tumor cancers

Indeterminate GlobeNewswire
Ocugen Announces Positive Preliminary Phase 2 Data from OCU410 Modifier Gene Therapy for Geographic Atrophy Secondary to Dry Age-Related Macular Degeneration
January 15, 2026

Ocugen Announces Positive Preliminary Phase 2 Data from OCU410 Modifier Gene Therapy for Geographic Atrophy Secondary to Dry Age-Related Macular Degeneration

Indeterminate GlobeNewswire
60 Degrees Pharmaceuticals, Inc. Announces Approval of Reverse Stock Split Ratio
January 15, 2026

60 Degrees Pharmaceuticals, Inc. Announces Approval of Reverse Stock Split Ratio

Indeterminate GlobeNewswire
HMNC Brain Health Presented Positive Phase 2b Data at American College of Neuropsychopharmacology Annual Meeting
January 15, 2026

HMNC Brain Health Presented Positive Phase 2b Data at American College of Neuropsychopharmacology Annual Meeting

Indeterminate GlobeNewswire
Show More

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions